Aussie8 – Lifestyle
Author:
CG Oncology Inc.
CG Oncology Reports Positive First Results from CORE‑008 Cohort CX Phase 2 Trial Evaluating Intravesical Combination Therapy in High-Risk BCG-Exposed and BCG-Unresponsive Patients
May 15, 2026
CG Oncology’s Presence at American Urological Association (AUA) Annual Meeting Underscores its Strong Commitment to NMIBC
May 11, 2026
CG Oncology Reports First Quarter 2026 Financial Results and Provides Business Updates
May 8, 2026
CG Oncology to Present at Upcoming Investor Conferences in May
May 5, 2026